Apuli Maricel
- SEC CIK
- 0002058197
In the past year, 5 open-market sale filings worth $621.7K and no purchases.
Current role at each company
- BBIO BridgeBio Pharma, Inc.Chief Accounting Officeras of Aug 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $621.7K
- 5 filings
- Net
- −$621.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Apuli Maricel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 (view filing)4:20 PM ET | Jul 30 | 4 days | Apuli MaricelChief Accounting Officer | SSale | −2.00K | $80.06 | −$160.1K | −1.5%127.4K after | 10b5-1 |
| May 4, 2026 (view filing) | Apr 30 | 4 days | Apuli MaricelChief Accounting Officer | SSale | −2.00K | $71.58 | −$143.2K | −1.5%134.1K after | 10b5-1 |
| Feb 27, 2026 (view filing) | Feb 26 | 1 day | Apuli MaricelChief Accounting Officer | SSale | −2.00K | $66.00 | −$132.0K | −1.6%121.9K after | 10b5-1 |
| Feb 18, 2026 (view filing) | Feb 17 | 1 day | Apuli MaricelChief Accounting Officer | SSale | −510 | $74.31 | −$37.9K | −0.4%123.9K after | 10b5-1 |
| Dec 10, 2025 (view filing) | Dec 8 | 2 days | Apuli MaricelChief Accounting Officer | SSale | −2.00K | $74.26 | −$148.5K | −1.5%130.3K after | 10b5-1 |
| Aug 11, 2025 (view filing) | Aug 7 | 4 days | Apuli MaricelChief Accounting Officer | SSale | −1.00K | $45.44 | −$45.4K | −0.7%141.9K after | |
| May 6, 2025 (view filing) | May 2 | 4 days | Apuli MaricelChief Accounting Officer | SSale | −1.03K | $38.51 | −$39.5K | −0.7%147.6K after |